Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2013-11-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
102年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 102年09月30日 (which corresponds to a quarter-end date). The presence of detailed financial statements with actual figures and percentages indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 4740 characters, which is sufficient to contain a financial report. The data corresponds to a quarterly period (third quarter of year 102 in the ROC calendar), indicating this is an Interim / Quarterly Report. There is no indication that this is an annual report, audit report, or other types of filings. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q3 2013
2013-11-13 Chinese
102年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a company over specific periods (e.g., 民國102年前3季, which corresponds to the first three quarters of 2013). The data includes items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and other equity items. This type of detailed financial data is typical of an Interim / Quarterly Report (IR), as it provides substantive financial data and analysis for a period shorter than a full fiscal year. The document length is 3881 characters, which is relatively short but contains actual financial data rather than just an announcement or certification. There is no indication that this is a full Annual Report (10-K) or just an announcement of a report (RPA). Therefore, the best classification is Interim / Quarterly Report (IR). 9M 2013
2013-11-13 Chinese
102年第3季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits, but it is relatively short (1329 characters) and does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure related to investment activities rather than a full financial report or earnings release. There is no indication of it being an announcement of a report publication or a certification. Given the nature and length, and the fact it is a regulatory disclosure of investment data, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2013-11-13 Chinese
101年第4季財務報告書 — 201204_3164_A06.pdf
Annual Report Classification · 100% confidence The document is titled as a consolidated financial statement and auditor's report for the fiscal years 101 and 100 (Taiwanese calendar years), which corresponds to a full annual period. It includes detailed financial statements such as the consolidated balance sheet, income statement, statement of changes in equity, and cash flow statement, along with extensive notes on accounting policies, related party transactions, and other disclosures. The presence of an auditor's report with an opinion on the financial statements further confirms this is a full annual report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2012
2013-11-13 Chinese
101年第4季財務報告書 — 201204_3164_A05.pdf
Annual Report Classification · 100% confidence The document is a comprehensive financial report for 景岳生物科技股份有限公司 covering fiscal years 民國101 (2012) and 100 (2011). It includes detailed financial statements such as the balance sheet, income statement, statement of changes in equity, and cash flow statement. It also contains extensive notes on accounting policies, company history, and auditor's report by a certified public accounting firm. The presence of full financial data, detailed accounting notes, and an auditor's opinion indicates this is a full annual financial report. The document length is about 15,000 characters, which is consistent with a full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2012
2013-11-13 Chinese
101年第4季財務報告書 — 201204_3164_A02.pdf
Annual Report Classification · 100% confidence The document is titled as a consolidated financial statement and auditor's report for the fiscal years 101 and 100 (likely referring to Taiwanese calendar years). It includes detailed consolidated financial statements such as the balance sheet, income statement, statement of changes in equity, and cash flow statement, along with notes and an auditor's report from a certified public accounting firm. The presence of the auditor's report and comprehensive financial data for a full fiscal year indicates this is a full annual report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2012
2013-11-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.